The Dow Jones Industrial Average jumped again today, riding a wave that carried the S&P 500 up 1.2% and lifted the Nasdaq 1.8%.
Keep Reading →
April 11 - News
Investors have been as clear as they can be about what they see as their ideal situation.
Keep Reading →
April 10 - News
The Dow Jones Industrial Average isn't just for industrial stocks anymore.
Keep Reading →
April 10 - News
As I noted six weeks ago, cancer statistics are both staggering and disappointing.
Keep Reading →
April 10 - News
Investors love stocks that consistently beat the Street without getting ahead of their fundamentals and risking a meltdown.
Keep Reading →
April 9 - News
Johnson & Johnson (NYSE:JNJ) was in 67 hedge funds' portfolio at the end of December. JNJ has experienced a decrease in hedge fund interest in recent months.
Keep Reading →
April 8 - News
In a previous article, I talked about the top position of one of Benjamin Graham's oldest students, Irving Kahn.
Keep Reading →
April 8 - News
Is the prestige really worth a place on the Dow Jones Industrial Average (Dow Jones Indices:.DJI)? Let's ask Pfizer Inc. (NYSE:PFE), Verizon Communications Inc.
Keep Reading →
April 8 - News
April showers might bring May flowers, but the first week of the new month has already seen several health-care stocks hit full bloom.
Keep Reading →
April 7 - News
What doesn't J&J produce? From pharmaceuticals to consumer care goods to medical devices, this major medical player has it all.
Keep Reading →
April 7 - News
Benjamin Graham’s oldest student, who is still alive, is 106-year-old Irving Kahn.
Keep Reading →
April 7 - Hedge Funds
Abbott Laboratories (NYSE:ABT) has begun its new future swimmingly.
Keep Reading →
April 5 - News
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis...
Keep Reading →
April 5 - News
Making money in business typically happens in one of two ways. You either sell a relatively low-cost product to a large number of customers.
Keep Reading →
April 4 - News
The Dow Jones Industrial Average 2 Minute rose higher by 89 points, or 0.61%, today, after positive factory orders data and a higher-than-expected Medicare reimbursement rate ...
Keep Reading →
April 3 - News
The index has hit a new intraday record high in its latest surge, and as of 2:15 p.m. EDT the Dow has advanced 95 points, or 0.6%.
Keep Reading →
April 2 - News
Dublin-based pharmaceutical and medical device company Covidien plc (NYSE:COV) recently announced that it had authorized a share buyback program that could be worth up to $2...
Keep Reading →
April 2 - News
The Dow Jones Industrial Average 2 Minute jumped this morning following a slight decline yesterday.
Keep Reading →
April 2 - News
It's been quite a while since we had a big wedding in the pharma world.
Keep Reading →
March 28 - News
After a wildly successful IPO that raised over $2 billion, and valued the newly-created company at more than $12 billion, pharmaceutical giant Pfizer Inc.
Keep Reading →
March 28 - News
There has been a significant rally in the share price of Celldex Therapeutics, Inc. (NASDAQ:CLDX) recently.
Keep Reading →
March 27 - News
Now more than ever, a comfortable retirement depends on secure, stable investments. Unfortunately, the right stocks for retirement won't just fall into your lap.
Keep Reading →
March 26 - News
Pfizer Inc. (NYSE:PFE) is the largest healthcare company in the world in terms of market capitalization.
Keep Reading →
March 26 - News
The biotech sector can occasionally throw a curveball at investors. For Trius Therapeutics, Inc.
Keep Reading →
March 26 - News
Will good news from Europe echo on this side of the Atlantic within the next few days? Biogen Idec Inc. (NASDAQ:BIIB) is certainly hoping so.
Keep Reading →
March 25 - News
The Dow Jones Industrial Average rose by 90 points on Friday -- the exact amount it fell the day before -- on hopes that a deal between the European Union and Cyprus would get...
Keep Reading →
March 25 - News
What doesn't J&J produce? From pharmaceuticals to consumer care goods to medical devices, this major medical player has it all.
Keep Reading →
March 25 - News
Big pharma loves Obamacare, right? After all, the main lobbying group for big pharma, the Pharmaceutical Researchers and Manufacturers of America, or PhRMA, spent $150 million...
Keep Reading →
March 23 - News
ACADIA Pharmaceuticals Inc.
Keep Reading →
March 22 - News
In this series, we'll highlight four companies in an industry, and compare their "cash king margins" over time, trying to determine which has the greatest likelihood of putting...
Keep Reading →
March 22 - News
It’s almost here! Johnson & Johnson (NYSE:JNJ) is eagerly awaiting a decision on its type 2 diabetes drug Invokana (canagliflozin) by the end of the month.
Keep Reading →
March 22 - News
Sometimes, as investors, we can lose sight of the bigger picture. We can get caught up in the latest fad and complex indicators, hoping to get an edge.
Keep Reading →
March 21 - News
In order to be in the top fifty companies with available cash, a company would have to have $4.9 billion in cash -- 69% higher than in 2006.
Keep Reading →
March 21 - News
The demand for drugs worldwide is expected to increase due to emerging markets abroad and more specifically, due to an influx of demand from the aging "Baby Boomers" domestically...
Keep Reading →
March 20 - News
As I noted three weeks ago, cancer statistics are both staggering and disappointing.
Keep Reading →
March 20 - News
There were cheers for joy when Abbott Laboratories (NYSE:ABT) announced that it would split itself into two entities -- separating the device and diagnostics businesses from ...
Keep Reading →
March 19 - News
Despite my recent obsession with Johnson & Johnson (NYSE:JNJ)'s restoration to health, I've long been a closet admirer of rival Pfizer Inc. (NYSE:PFE).
Keep Reading →
March 19 - News
One thing that many investors become fixated on is always wanting the next 'hot tip' or the 'inside word.' Forever seeking an edge on everyone else, investors seek the holy grail...
Keep Reading →
March 18 - News
Shares of Johnson & Johnson (NYSE:JNJ) have climbed 16% over the past five months and as of this writing, the stock is making new 52-week highs.
Keep Reading →
March 18 - News
With interest rates still sitting near record lows, investors looking for current income have been forced to move from fixed-income positions and into stocks to find yield.
Keep Reading →
March 18 - Dividend Stocks
The nationwide banking holiday declared by incoming President Franklin D. Roosevelt could have ended in disaster.
Keep Reading →
March 15 - News
Now more than ever, a comfortable retirement depends on secure, stable investments. Unfortunately, the right stocks for retirement won't just fall into your lap.
Keep Reading →
March 13 - News
The Motley Fool recently published its list of The 25 Best Companies in America and while Bristol-Myers Squibb Co.
Keep Reading →
March 12 - News
The Motley Fool recently whittled down 1,700 public companies to name its list of The 25 Best Companies in America. Merck & Co., Inc.
Keep Reading →
March 12 - News
If you asked the average person on the street if America is overpopulated and the birth rate is too high, you'd likely receive "Yes" as your answer.
Keep Reading →
March 11 - News
Earnings season is winding down, with most companies already having reported their quarterly results.
Keep Reading →
March 11 - News
The Dow Jones Industrial Average 2 Minute (Dow Jones Indices:.DJI) gained more than 300 points, or 2.18%, this week, and set a new record high in each of the past four days.
Keep Reading →
March 10 - News
One of my favorite Warren Buffett quotes is that it’s far better to buy a wonderful company trading at a fair price than a fair company trading at a wonderful price. While...
Keep Reading →
March 10 - News
It took more than five years, but the Dow Jones Industrial Average 2 Minute (Dow Jones Indices: .DJI) has officially surpassed its previous record.
Keep Reading →
March 8 - News